AAA
VRNA
Affinity Asset Advisors’s Verona Pharma VRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.7M | Sell |
610,000
-5,000
| -0.8% | -$473K | 7.88% | 1 |
|
|
2025
Q1 | $39M | Sell |
615,000
-45,000
| -7% | -$2.86M | 3.73% | 3 |
|
|
2024
Q4 | $30.7M | Buy |
660,000
+10,000
| +2% | +$464K | 4.11% | 6 |
|
|
2024
Q3 | $18.7M | Sell |
650,000
-50,000
| -7% | -$1.44M | 2.55% | 11 |
|
|
2024
Q2 | $10.1M | Sell |
700,000
-117,833
| -14% | -$1.7M | 1.17% | 23 |
|
|
2024
Q1 | $13.2M | Buy |
817,833
+254,009
| +45% | +$4.09M | 1.63% | 14 |
|
|
2023
Q4 | $11.2M | Buy |
563,824
+195,495
| +53% | +$3.89M | 2.05% | 17 |
|
|
2023
Q3 | $6M | Sell |
368,329
-79,338
| -18% | -$1.29M | 1.69% | 18 |
|
|
2023
Q2 | $9.46M | Sell |
447,667
-5,154
| -1% | -$109K | 3.31% | 10 |
|
|
2023
Q1 | $9.09M | Buy |
452,821
+140,323
| +45% | +$2.82M | 3% | 8 |
|
|
2022
Q4 | $8.17M | Sell |
312,498
-37,502
| -11% | -$980K | 3.2% | 7 |
|
|
2022
Q3 | $3.58M | Buy |
+350,000
| New | +$3.58M | 1% | 25 |
|